Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterogeneity in statin responses explained by variation in the human gut microbiome

11 May 2022

Abstract excerpt

BACKGROUND: Statins remain one of the most prescribed medications worldwide. While effective in decreasing atherosclerotic cardiovascular disease risk, statin use is associated with adverse effects for a subset of patients, including disrupted metabolic control and increased risk of type 2 diabetes. METHODS: We investigated the potential role of the gut microbiome in modifying patient responses to statin therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Lipoproteins and Cardiovascular Health
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35690059
DOI: 10.1016/j.medj.2022.04.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Heterogeneity in statin responses explained by variation in the human gut microbiomePMID 35690059Read ↗

Enteric microbiome metabolites correlate with response to simvastatin treatment.Semantic proximity Read ↗

Simvastatin induces human gut bacterial cell surface genesSemantic proximity Read ↗

Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.Semantic proximity Read ↗

Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathwaySemantic proximity Read ↗

Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy AdultsSemantic proximity Read ↗

Omeprazole and cardiovascular risk via induction of statin dysmetabolismSemantic proximity Read ↗

Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteriaSemantic proximity Read ↗

Mirror, mirror on the wall: which microbiomes will help heal them all?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.